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Convulsions Induced by 2-N-Di-n-Butylaminoethanol. HARTUNG, ROLF, 
PITTLE, LESTER B., and CORNISH, HERBERT, H. (1970). Toxicol. Appl. 
Pharmacol. 17, 337-343. Dibutylaminoethanol (Bu,AE) produces convul- 
sions in rats leading to respiratory arrest regardless of route of administra- 
tion. The lethality of 5 x LD50 doses of BuzAE can be readily overcome by 
artificial respiration for 2-4 hr. In vivo phrenic nerve-diaphragm prepara- 
tions indicate that the respiratory arrest is due to a neuromuscular blockade. 
Spontaneous activity of the phrenic nerve increases during convulsions and 
persists during blockade. Pretreatment with mephenesin or diphenylhydan- 
toin, but not pentobarbital, was effective in counteracting convulsions and 
respiratory arrest. BuzAE has also been shown to be a moderate inhibitor 
of acetylcholinesterase. It is proposed that the increased nerve activity 
during convulsions with its simultaneous increase in acetylcholine release, 
acts in concert with the moderate level of cholinesterase inhibition, produc- 
ing a neuromuscular blockade due to excessive acetylcholine accumulation 
at the junction. 
Dibutylaminoethanol (Bu,AE) has found use as a conditioning agent for cellulose ace- 
tate filaments to facilitate textile manufacture, a catalyst in polyurethane foam manu- 
facture, an anticorrosion additive for lubricants and hydraulic fluids, in the manufacture 
of emulsifying and dispersing agents, and in the curing of silicone resins. 
Bu,AE has been investigated by us because it is one of the more toxic in a long series 
of alkyl-substituted aminoethanols. The oral LD50 of this compound has been reported 
as 1.07 g/kg by Smyth et al. (1954). Cornish et al. (1969) found that Bu2AE in drinking 
water at 0.2 and 0.4 g/kg per day in rats resulted in reduced body weight and slight 
increases in kidney weight without accompanying pathology. Inhalation studies at 70 
ppm for 6 hr daily for 5 days, resulted in weight losses, chromodacryorrhea, tremors, and 
some convulsions. At that dose level there was 20 % mortality. 
Characteristically Bu,AE acts by inducing strong clonic-tonic convulsions which 
closely resemble a Grand Ma1 seizure. These convulsions were noted after oral and intra- 
peritoneal administrations as well as inhalation of Bu,AE. All observed mortalities due 
to Bu,AE were preceded by convulsions. Because of this close relationship, they were 
studied in greater detail. 
METHODS 
There appeared to be no qualitative difference in the convulsions associated with 
acute or subchronic exposures or with variations in route of administration. Therefore 
1 Presented in part at the 1969 Society of Toxicology meeting, Williamsburg, Virginia. 
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the following series of experiments were standardized using ip injections of Bu,AE. 
Male Sprague-Dawley rats (Spartan strain) were used throughout. 
Like most alkyl-substituted aminoethanols, BuzAE is normally quite alkaline with a 
pK, of9.67 (Gero, 1963). Prior to use, commercial Bu,AE(Eastman Organic Chemicals) 
was further purified by fractional vacuum distillation. It was then neutralized with 
HCI to avoid the direct effects of alkalinity. Doses are reported in terms of Bu,AE base. 
Statistical analyses of the ED50 and LD50 data were done using the logistic analysis of 
Berkson (1944), which we have programmed for computer use. Electroencephalograms 
were taken under pentobarbital anesthesia between right frontal and right parietal 
areas with the electrodes directly attached to the skull. In viva nerve-diaphragm prepara- 
tions were prepared as illustrated in Fig. 1. Mathematical analysis of nerve activity was 
done by computer-assisted polynomial regression. 
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FIG. 1. Experimental configuration for measuring spontaneous phrenic nerve activity and for 
simultaneous determination of threshold voltage for stimulation of contraction of the rat diaphragm. 
RESULTS 
After ip injection the median effective dose for the production of convulsions was 
50.6 mg/kg (95 % fiducial limits: 31.6-80.9), and the LD50 was found to be 89.1 mg/kg 
(95 % fiducial limits: 40.6-195.6). There is a significant overlap between convulsive 
dose and lethal dose. Many of the rats which reached the convulsive stage also died. 
Shortly after Bu,AE injection, there appears to be an increase in rhythmic electrical 
activity of the EEG which becomes very pronounced during the ensuing convulsions 
(Fig. 2). In this case, these convulsions were reduced to very heavy tremors under the 
influence of the barbiturate anesthesia. During light pentobarbital anesthesia, the rat 
will frequently wake up after Bu,AE and shortly go into frank convulsions. The convul- 
sions then lead to a respiratory arrest and a flattening of the EEG due to anoxia. The 
convulsions arose centrally as indicated by the EEG and substantiated by the fact that 
convulsions disappeared distally upon spinal section. 
The immediate cause of death after Bu,AE appears to be the respiratory arrest which 
follows immediately after the convulsions. We attempted to counteract the respiratory 
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arrest phase by artificial respiration after doses up to 500 mg/kg ip Bu,AE. This repre- 
sents approximately 5-6 LD50. The rats were placed under light pentobarbital anes- 
thesia and respired via a tracheal cannula using a Physiograph respirator. After an 
initial period of moderate convulsions and tremors, the experimental animals stopped 
breathing spontaneously, as tested by briefly interrupting the artificial respiration. The 
animals did not develop cyanosis at any time during this treatment. The artificial respira- 
tion counteracted the respiratory failure, but not the convulsions. 
After the convulsive phase, the animals appeared to be in a generalized state of 
flaccid paralysis for 2-4 hr. After these 2-4 hr of artificial respiration, all animals were 
able to resume breathing on their own and were able to walk a short time after that. 
When function was regained, the signs of tremors and convulsions did not reappear. 
FIG. 2. EEG-right frontal to right parietal; electrodes placed on the surface of the skull in a rat after 
250 mg/kg ip BQAE. 
Since artificial respiration was effective in counteracting the lethality of Bu,AE due 
to respiratory arrest without appreciably affecting the convulsions, we investigated the 
nature of that respiratory arrest. For this investigation, we utilized the in uivo nerve- 
diaphragm preparation as illustrated in Fig. 1. We were thus able to measure the spon- 
taneous activity of the intact phrenic nerve, and also were able to study the effect of 
stimulating the phrenic nerve on the contractility of the rat diaphragm. Stimulating the 
phrenic nerve indicated that a neuromuscular blockade developed whose onset was dose 
related (Fig. 3). For individual rats within these groups, the onset of the blockade was 
typically abrupt. There also was a general indication that the severity of the blockade 
was dose related. 
The recordings of spontaneously occurring nerve activity exhibited a great deal more 
variability. The basic method of measurement, using a scaler and counting all impulses 
above a certain threshold voltage, plainly suffered from lack of sophistication and 
equipment. Nevertheless, the data in Fig. 4 demonstrate that some activity in the intact 
phrenic nerve persists even during the neuromuscular blockade, and that there is a 
trend toward higher nerve activity for higher dose levels of Bu,AE. Much of that increase 
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occurs during the convulsive stage and is probably due to the increased central 
stimulation after Bu,AE. 
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FIG. 3. Polynomial regressions (5th degree) of threshold voltages for phrenic nerve stimulation elicit- 
ing contraction of the diaphragm. Time of injection is at 0 min; dosages are indicated as mg/kg ip of 
Bu2AE. 400 mg/kg: No. of rats (NR) = 5, No. of determinations (ND) = 299, F value = 72.40; 300 
mg/kg:NR=5,ND=332,F=23.50;200mg/kg:NR=8,ND=500,F=27.15;100mg/kg:NR=2, 
ND = 137, F= 205.53; 0 mg/kg: NR = 2, ND = 137, F= -. 
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FIG. 4. Polynomial regressions (5th degree) of relative spontaneous phrenic nerve activity. Time of 
injection is at 0 min, dosages are indicated as mg/kg ip of BQAE. 400 mg/kg: NR = 5, ND = 391, 
F= 7.01; 300 mg/kg: NR = 5, ND = 332, F= 0.59; 200 mg/kg: NR = 8, ND = 500, F= 21.99; 
100 mg/kg: NR = 2, ND = 139, F= 38.62; 0 mg/kg: NR = 2, ND = 78, F= 6.98. 
Many of the preceding data of course had to be gathered during artificial respiration. 
Without artificial respiration or other treatment, the time course of these events is 
normally quite short. At 250 mg/kg, which represents approximately a 3 x LD50 dose, 
time to first convulsion was typically 2.9 & 0.3 (mean f SE) min and time to death 
DIBUTYLAMINOETHANOL CONVULSIONS 341 
TABLE 1 































































Time to 1st Time to 
convulsion, death, 
tc td 










































































































































342 HARTUNG, PITTLE, AND CORNISH 
7.8 i 1 .O min. Under these conditions, the mortality was 100 % in 10 experiments. The 
same dose was used in most of the subsequent experiments which tested various Bu,AE 
drug interrelations. 
We had previously demonstrated that Bu,AE was a moderately active inhibitor of 
acetylcholinesterase (Hartung and Cornish, 1968). Therefore, we investigated the effect 
of pretreatment with atropine on Bu,AE-induced convulsions. The Bu,AE was injected 
when atropinization had been achieved, as judged by pupil size. Dosages of atropine 
ranging from 0.02 to 0.2 mg/kg had no significant effect on the time course or the out- 
come of convulsions and respiratory arrest induced by Bu,AE doses as low as 125 
mg/kg. Since atropine is mainly effective in counteracting the parasympathomimetic 
effects of anticholinesterases, but not neuromuscular effects, these results were not un- 
expected. 
The possibility still remained that this was a curarelike neuromuscular blockade. 
Therefore we employed 0.85 mg/kg iv edrophonium, which is a valuable antagonist 
against some curariform neuromuscular blockers. It too had no effect on the time course 
or outcome. 
Since none of the tested peripherally acting antagonists to neuromuscular blocking 
agents had been effective in counteracting Bu2AE toxicity, we decided to test some of 
the centrally acting anticonvulsants. 
Throughout our work with anesthetized rats we had noted that barbiturates in 
moderate doses were unable to control Bu*AE-induced convulsions. Therefore we in- 
vestigated a series of other anticonvulsants. 
Magnesium sulfate (1 mg/kg iv) given as pretreatment resulted in 1 survival in 6. The 
significance of that effect may be questionable. Higher dose levels may be more 
effective. 
Mephenesin was far more effective as an anticonvulsant against Bu,AE (Table 1). 
In these tests, a curious effect became evident. Animals which did not develop convul- 
sions, survived without developing any indication of respiratory arrest. When the onset 
of convulsions could be delayed to 6 min, the rats usually survived. In those cases the 
convulsions were much weaker and alternated with heavy tremors for as long as 1.5 hr 
without producing a respiratory arrest. 
Diphenylhydantoin (5 mg/kg iv) was the most effective drug for preventing Bu,AE- 
induced convulsions (Table 2). It almost completely prevented convulsions and mor- 
talities after normally lethal doses of Bu*AE. 
On the other hand, trimethadione was ineffective in controlling Bu,AE-induced 
convulsions even at doses (150 mg/kg ip) which had been found effective in counter- 
acting a lethal dose of the convulsant pentylenetetrazol. 
DISCUSSION 
Bu*AE has been shown to produce convulsions and neuromuscular blockade result- 
ing in respiratory arrest. None of the peripherially acting drugs selected for possible 
antagonistic action to the neuromuscular blockade produced by Bu,AE had any notice- 
able effect. However, two centrally acting anticonvulsants were effective in counter- 
acting both the convulsive seizures and the respiratory arrest produced by Bu,AE. 
Thus for BuzAE there appears to be a relationship between the primary mechanism 
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causing convulsions and the subsequent neuromuscular blockade which results in 
death due to respiratory arrest. 
Bu,AE appears to possess a duality in its mode of action. First, it produces a greatly 
increased CNS activity which results in strong tonic-clonic convulsions. Respiratory 
arrest due to the neuromuscular blockade develops during this period of elevated CNS 
activity. Since Bu,AE is also a moderate acetylcholinesterase inhibitor, this increased 
nerve activity with its simultaneous increase in release of acetylcholine at the junction, 
may result in a neuromuscular blockade due to excess acetylcholine at that site. 
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